These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7563316)

  • 1. Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation.
    Khatchadourian J; Preminger GM; Whitson PA; Adams-Huet B; Pak CY
    J Urol; 1995 Nov; 154(5):1665-9. PubMed ID: 7563316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis.
    Pak CY; Moe OW; Sakhaee K; Peterson RD; Poindexter JR
    J Urol; 2005 May; 173(5):1606-9. PubMed ID: 15821508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis.
    Pak CY; Poindexter JR; Peterson RD; Koska J; Sakhaee K
    Urology; 2002 Nov; 60(5):789-94. PubMed ID: 12429297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium oxalate stone and gout.
    Marickar YM
    Urol Res; 2009 Dec; 37(6):345-7. PubMed ID: 19779706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic values of urinary citrate for kidney stones in patients with primary gout].
    Wang Y; Zhang HM; Deng XR; Liu WW; Chen L; Zhao N; Zhang XH; Song ZB; Geng Y; Ji LL; Wang Y; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1134-1140. PubMed ID: 36533345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gouty diathesis and sarcoidosis in patient with recurrent calcium nephrolithiasis.
    Harvey JA; Pak CY
    J Urol; 1988 Jun; 139(6):1287-9. PubMed ID: 3373603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical profile of stone-forming patients with diabetes mellitus.
    Pak CY; Sakhaee K; Moe O; Preminger GM; Poindexter JR; Peterson RD; Pietrow P; Ekeruo W
    Urology; 2003 Mar; 61(3):523-7. PubMed ID: 12639639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who makes uric acid stones and why--observations from a renal stones clinic.
    Stansbridge EM; Griffin DG; Walker V
    J Clin Pathol; 2013 May; 66(5):426-31. PubMed ID: 23454727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Changes in Kidney Stone Composition and in Risk Factors Predisposing to Stone Formation.
    Xu LHR; Adams-Huet B; Poindexter JR; Maalouf NM; Moe OW; Sakhaee K
    J Urol; 2017 Jun; 197(6):1465-1471. PubMed ID: 28111301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of patients with staghorn calculi in our experience.
    Akagashi K; Tanda H; Kato S; Ohnishi S; Nakajima H; Nanbu A; Nitta T; Koroku M; Sato Y; Hanzawa T
    Int J Urol; 2004 May; 11(5):276-81. PubMed ID: 15147542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary alkalization for the treatment of uric acid nephrolithiasis.
    Cicerello E; Merlo F; Maccatrozzo L
    Arch Ital Urol Androl; 2010 Sep; 82(3):145-8. PubMed ID: 21121431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and prevention of uric acid stones].
    Ferrari P; Bonny O
    Ther Umsch; 2004 Sep; 61(9):571-4. PubMed ID: 15493118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and dietary factors of uric acid stone formation.
    Trinchieri A; Montanari E
    Urolithiasis; 2018 Apr; 46(2):167-172. PubMed ID: 28246885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Types for 1 849 patients with urinary calculi and patients' clinical characteristics].
    Xue J; Wang C; Jiang Z; Tan J; Liu D; Chen B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 43(8):852-857. PubMed ID: 30197312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid nephrolithiasis: current concepts and controversies.
    Shekarriz B; Stoller ML
    J Urol; 2002 Oct; 168(4 Pt 1):1307-14. PubMed ID: 12352383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can 24-hour urine stone risk profiles predict urinary stone composition?
    Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
    J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and urinary stone composition: what factors matter most?
    Kadlec AO; Greco K; Fridirici ZC; Hart ST; Vellos T; Turk TM
    Urology; 2012 Oct; 80(4):805-10. PubMed ID: 22795374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some unusual features of gouty arthritis in females.
    Yü TF
    Semin Arthritis Rheum; 1977 Feb; 6(3):247-55. PubMed ID: 835022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.